Basal cell carcinoma (BCC) is the most common human malignancy and by far the most prevalent form of skin cancer, accounting for more than 80% of all cases.
Sherrif F. Ibrahim, MD, PhD
Advertisement
Articles by Sherrif F. Ibrahim, MD, PhD
Advertisement
Latest Updated Articles
Update on Vismodegib's Place in the Treatment of Advanced BCCAugust 18th 2014
Advertisement
Advertisement
Trending on OncLive
1
Pumitamig Plus Elfetabart Drozuntecan Elicits 70% ORR Across Lines of Therapy in SCLC
2
SERENA-4 Misses Primary PFS End Point With Camizestrant Plus Palbociclib in First-Line ER+ Advanced Breast Cancer
3
Extended-Interval Tarlatamab Yields Comparable Exposure, Survival to Q2W Dose in Previously Treated SCLC
4
LCT After Nivolumab/Ipilimumab Induction Fails to Improve Metastatic NSCLC Survival
5